| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
536 |
| issn |
0012-6667
1179-1950 |
| issueIdentifier |
4 |
| pageRange |
521-536 |
| publicationName |
Drugs |
| startingPage |
521 |
| bibliographicCitation |
Keating GM, Plosker GL. Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels. Drugs. 2005;65(4):521–36. doi: 10.2165/00003495-200565040-00006. PMID: 15733013. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8588bebd7f8d15d5154ba1b374e5279d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37d261092ea41b9bd83d6e194af7e990 |
| date |
200503 |
| identifier |
https://doi.org/10.2165/00003495-200565040-00006
https://pubmed.ncbi.nlm.nih.gov/15733013 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
https://portal.issn.org/resource/ISSN/1179-1950
https://portal.issn.org/resource/ISSN/0012-6667 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels |
| discusses |
http://id.nlm.nih.gov/mesh/M0019062
http://id.nlm.nih.gov/mesh/M0000620
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0017182
http://id.nlm.nih.gov/mesh/M0025711
http://id.nlm.nih.gov/mesh/M0552528
http://id.nlm.nih.gov/mesh/M0263641
http://id.nlm.nih.gov/mesh/M0018641 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10399 |